# China NMPA Inspection - Guangzhou Huajishang Biotechnology Co., Ltd. - October 19, 2020

Source: https://www.globalkeysolutions.net/records/china_inspection/guangzhou-huajishang-biotechnology-co-ltd/0df0d868-2dc7-45f8-9845-91bd616b68b6/
Source feed: China

> China NMPA unannounced inspection for Guangzhou Huajishang Biotechnology Co., Ltd. published October 19, 2020. The National Medical Products Administration (NMPA) recently conducted an unannounced inspection of Guangzhou Huajishang Biotechnology Co., Ltd., with

---

## Details

- Record Type: CHINA_INSPECTION
- Title: Announcement No. 69 of 2020 from the National Medical Products Administration regarding the suspension of production and rectification of Guangzhou Huajishang Biotechnology Co., Ltd.
- Company Name: Guangzhou Huajishang Biotechnology Co., Ltd.
- Publication Date: 2020-10-19
- Product Type: cosmetics
- Summary: The National Medical Products Administration (NMPA) recently conducted an unannounced inspection of Guangzhou Huajishang Biotechnology Co., Ltd., with findings announced on October 19, 2020. The inspection revealed serious violations of the "Cosmetics Production Licensing Work Specifications," indicating significant deficiencies in the company's quality management system. Key issues included personnel lacking necessary microbiology testing knowledge, and widespread failures in quality management such as absent autoclave usage records, incomplete original testing records, and unsigned microbiology documents. Extensive problems in factory and facilities involved non-functional handwashing facilities, direct staff entry into cleanrooms from non-clean areas, lack of environmental monitoring, storage of personal items and waste in cleanrooms, inadequate differential pressure control, structural damage, and poor hygiene in storage areas. Equipment lacked proper status and identification labels, and material management was deficient with failures in incoming goods inspection and improper raw material storage. Production records for specific products were also incomplete. As a result, the NMPA has ordered Guangzhou Huajishang Biotechnology Co., Ltd. to immediately suspend all cosmetic production. The company must complete comprehensive rectification and pass a follow-up inspection by the Guangdong Provincial Drug Administration before resuming operations, with potential severe penalties for any illegal activities discovered.

Company: https://www.globalkeysolutions.net/companies/guangzhou-huajishang-biotechnology-co-ltd/f486d599-212e-42eb-b51a-b8b59b1a4ff1/